Ovarian damage from chemotherapy and current approaches to its protection
Open accessThe DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Abstract
Background: Anti-cancer therapy is often a cause of premature ovarian insufficiency and infertility since the ovarian follicle reserve is extremely sensitive to the effects of chemotherapy and radiotherapy. While oocyte, embryo and ovarian cortex cryopreservation can help some women with cancer-induced infertility achieve pregnancy, the development of effective methods to protect ovarian function during chemotherapy would be a significant advantage. Objective and rationale: This paper critically discusses the different damaging effects of the most common chemotherapeutic compounds on the ovary, in particular, the ovarian follicles and the molecular pathways that lead to that damage. The mechanisms through which fertility-protective agents might prevent chemotherapy drug-induced follicle loss are then reviewed. Search methods: Articles published in English were searched on PubMed up to March 2019 using the following terms: ovary, fertility preservation, chemotherapy, follicle death, adjuvant therapy, cyclophosphamide, cisplatin, doxorubicin. Inclusion and exclusion criteria were applied to the analysis of the protective agents. Outcomes: Recent studies reveal how chemotherapeutic drugs can affect the different cellular components of the ovary, causing rapid depletion of the ovarian follicular reserve. The three most commonly used drugs, cyclophosphamide, cisplatin and doxorubicin, cause premature ovarian insufficiency by inducing death and/or accelerated activation of primordial follicles and increased atresia of growing follicles. They also cause an increase in damage to blood vessels and the stromal compartment and increment inflammation. In the past 20 years, many compounds have been investigated as potential protective agents to counteract these adverse effects. The interactions of recently described fertility-protective agents with these damage pathways are discussed. Wider implications: Understanding the mechanisms underlying the action of chemotherapy compounds on the various components of the ovary is essential for the development of efficient and targeted pharmacological therapies that could protect and prolong female fertility. While there are increasing preclinical investigations of potential fertility preserving adjuvants, there remains a lack of approaches that are being developed and tested clinically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Emidio, G. D., Rossi, G., Bonomo, I., Alonso, G. L., Sferra, R., Vetuschi, A., Artini, P. G., Provenzani, A., Falone, S., Carta, G., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8928604 · Cited by 65
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335 · cited 2×
“The CISinduced DNA adducts are recognised by damage recognition proteins which transduce the DNA damage signal downstream and modulate several signal transduction pathways, such as Akt, c-ABL, ATR and MAPK/JNK/ERK (Siddik, 2003; Wang and Lippard, 2005).”
BackgroundDoxorubicin pathways: pharmacodynamics and adverse effects
Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ffb56 · Cited by 1,648
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996) · Nature · doi:10.1038/381800a0 · Cited by 1,529
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A., Howlader, N., Henley, S. J., Anderson, R. N., Firth, A. U., Ma, J., et al. (2018) · Cancer · doi:10.1002/cncr.31551 · Cited by 1,485
Self-citationAdriamycin: A New Anticancer Drug with Significant Clinical Activity
BLUM, R. H., & CARTER, S. K. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-2-249 · Cited by 1,057
Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
Kawamura, K., Cheng, Y., Suzuki, N., Deguchi, M., Sato, Y., Takae, S., Ho, C.-H., Kawamura, N., Tamura, M., Hashimoto, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312830110 · Cited by 863
Oocyte-Specific Deletion of Pten Causes Premature Activation of the Primordial Follicle Pool
Reddy, P., Liu, L., Adhikari, D., Jagarlamudi, K., Rajareddy, S., Shen, Y., Du, C., Tang, W., Hämäläinen, T., Peng, S. L., et al. (2008) · Science · doi:10.1126/science.1152257 · Cited by 856
Fertility Preservation in Women
Donnez, J., & Dolmans, M.-M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1614676 · Cited by 853
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
Soldani, C., & Scovassi, A. I. (2002) · Apoptosis · doi:10.1023/a:1016119328968 · Cited by 697
Morita, Y., Perez, G. I., Paris, F., Miranda, S. R., Ehleiter, D., Haimovitz-Friedman, A., Fuks, Z., Xie, Z., Reed, J. C., Schuchman, E. H., et al. (2000) · Nature Medicine · doi:10.1038/80442 · Cited by 588
Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations
Venegas, C., García, J. A., Escames, G., Ortiz, F., López, A., Doerrier, C., García‐Corzo, L., López, L. C., Reiter, R. J., & Acuña‐Castroviejo, D. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00931.x · Cited by 577
p63 protects the female germ line during meiotic arrest
Suh, E.-K., Yang, A., Kettenbach, A., Bamberger, C., Michaelis, A. H., Zhu, Z., Elvin, J. A., Bronson, R. T., Crum, C. P., & McKeon, F. (2006) · Nature · doi:10.1038/nature05337 · Cited by 549
Kalich-Philosoph, L., Roness, H., Carmely, A., Fishel-Bartal, M., Ligumsky, H., Paglin, S., Wolf, I., Kanety, H., Sredni, B., & Meirow, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005402 · Cited by 542
Green, D. M., Sklar, C. A., Boice, J. D., Mulvihill, J. J., Whitton, J. A., Stovall, M., & Yasui, Y. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1839 · Cited by 512
Hormone-replacement therapy: current thinking
Lobo, R. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 484
Crosstalk between Oxidative Stress and SIRT1: Impact on the Aging Process
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023834 · Cited by 452
Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth
John, G. B., Gallardo, T. D., Shirley, L. J., & Castrillon, D. H. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.06.017 · Cited by 425
Lambertini, M., Moore, H. C. F., Leonard, R. C. F., Loibl, S., Munster, P., Bruzzone, M., Boni, L., Unger, J. M., Anderson, R. A., Mehta, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.0858 · Cited by 393
Self-citationHahn, K. M. E., Johnson, P. H., Gordon, N. B., Kuerer, H. M., Middleton, L. P., Ramirez, M. M., Yang, W. T., Perkins, G. H., Hortobágyi, G. N., & Theriault, R. L. (2006) · Cancer · doi:10.1002/cncr.22081 · Cited by 385
Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles
Adhikari, D., Zheng, W., Shen, Y., Gorre, N., Hamalainen, T., Cooney, A. J., Huhtaniemi, I., Lan, Z.-J., & Liu, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp483 · Cited by 369
Chemotherapy-Induced Damage to Ovary: Mechanisms and Clinical Impact
Bedoschi, G., Navarro, P. A., & Oktay, K. (2016) · Future Oncology · doi:10.2217/fon-2016-0176 · Cited by 356
Perez, G. I., Knudson, C. M., Leykin, L., Korsmeyer, S. J., & Tilly, J. L. (1997) · Nature Medicine · doi:10.1038/nm1197-1228 · Cited by 353
New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics
Tokarska-Schlattner, M., Zaugg, M., Zuppinger, C., Wallimann, T., & Schlattner, U. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.06.009 · Cited by 350
Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death
Gonfloni, S., Di Tella, L., Caldarola, S., Cannata, S. M., Klinger, F. G., Di Bartolomeo, C., Mattei, M., Candi, E., De Felici, M., Melino, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.2033 · Cited by 346
Self-citationMeirow, D., Dor, J., Kaufman, B., Shrim, A., Rabinovici, J., Schiff, E., Raanani, H., Levron, J., & Fridman, E. (2007) · Human Reproduction · doi:10.1093/humrep/dem027 · Cited by 341
Chow, E. J., Stratton, K. L., Leisenring, W. M., Oeffinger, K. C., Sklar, C. A., Donaldson, S. S., Ginsberg, J. P., Kenney, L. B., Levine, J. M., Robison, L. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00086-3 · Cited by 320
Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
Carlsson, I. B. (2006) · Human Reproduction · doi:10.1093/humrep/del165 · Cited by 294
Anderson, R. A., Mitchell, R. T., Kelsey, T. W., Spears, N., Telfer, E. E., & Wallace, W. H. B. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00039-x · Cited by 293
Self-citationOocyte cryopreservation: where are we now?
Argyle, C. E., Harper, J. C., & Davies, M. C. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw007 · Cited by 291
Oktem, O., & Oktay, K. (2007) · Cancer · doi:10.1002/cncr.23071 · Cited by 289
Reversal of Female Infertility by Chk2 Ablation Reveals the Oocyte DNA Damage Checkpoint Pathway
Bolcun-Filas, E., Rinaldi, V. D., White, M. E., & Schimenti, J. C. (2014) · Science · doi:10.1126/science.1247671 · Cited by 277
Soleimani, R., Heytens, E., Darzynkiewicz, Z., & Oktay, K. (2011) · Aging · doi:10.18632/aging.100363 · Cited by 274
Kerr, J. B., Hutt, K. J., Michalak, E. M., Cook, M., Vandenberg, C. J., Liew, S. H., Bouillet, P., Mills, A., Scott, C. L., Findlay, J. K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.017 · Cited by 263
The impact of cancer on subsequent chance of pregnancy: a population-based analysis
Anderson, R. A., Brewster, D. H., Wood, R., Nowell, S., Fischbacher, C., Kelsey, T. W., & Wallace, W. H. B. (2018) · Human Reproduction · doi:10.1093/humrep/dey216 · Cited by 254
Self-citationDemeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Dupuis, J., Zachee, P., Casasnovas, O., Van Den Neste, E., Dechene, J., De Maertelaer, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.8864 · Cited by 240
Negative regulation of inflammation by SIRT1
Xie, J., Zhang, X., & Zhang, L. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.010 · Cited by 234
Targeting the ATR-CHK1 Axis in Cancer Therapy
Rundle, S., Bradbury, A., Drew, Y., & Curtin, N. (2017) · Cancers · doi:10.3390/cancers9050041 · Cited by 231
Meirow, D., Epstein, M., Lewis, H., Nugent, D., & Gosden, R. G. (2001) · Human Reproduction · doi:10.1093/humrep/16.4.632 · Cited by 229
van Dorp, W., Haupt, R., Anderson, R. A., Mulder, R. L., van den Heuvel-Eibrink, M. M., van Dulmen-den Broeder, E., Su, H. I., Winther, J. F., Hudson, M. M., Levine, J. M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.3441 · Cited by 229
Self-citationSeeliger, M. A., Nagar, B., Frank, F., Cao, X., Henderson, M. N., & Kuriyan, J. (2007) · Structure · doi:10.1016/j.str.2007.01.015 · Cited by 221
Chemaitilly, W., Li, Z., Krasin, M. J., Brooke, R. J., Wilson, C. L., Green, D. M., Klosky, J. L., Barnes, N., Clark, K. L., Farr, J. B., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3723 · Cited by 216
AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy
Kano, M., Sosulski, A. E., Zhang, L., Saatcioglu, H. D., Wang, D., Nagykery, N., Sabatini, M. E., Gao, G., Donahoe, P. K., & Pépin, D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620729114 · Cited by 208
Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation
Grosbois, J., & Demeestere, I. (2018) · Human Reproduction · doi:10.1093/humrep/dey250 · Cited by 208
Long-term toxicity of cisplatin in germ-cell tumor survivors
Chovanec, M., Abu Zaid, M., Hanna, N., El-Kouri, N., Einhorn, L. H., & Albany, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx360 · Cited by 204
Peripheral Reproductive Organ Health and Melatonin: Ready for Prime Time
Reiter, R., Rosales-Corral, S., Manchester, L., & Tan, D.-X. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047231 · Cited by 203
Del Mastro, L., Ceppi, M., Poggio, F., Bighin, C., Peccatori, F., Demeestere, I., Levaggi, A., Giraudi, S., Lambertini, M., D’Alonzo, A., et al. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.12.001 · Cited by 202
Morgan, S., Lopes, F., Gourley, C., Anderson, R. A., & Spears, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070117 · Cited by 180
Self-citationmTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy
Goldman, K. N., Chenette, D., Arju, R., Duncan, F. E., Keefe, D. L., Grifo, J. A., & Schneider, R. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617233114 · Cited by 180
Jang, H., Lee, O., Lee, Y., Yoon, H., Chang, E. M., Park, M., Lee, J., Hong, K., Kim, J. O., Kim, N. K., et al. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12316 · Cited by 177
Chemoprotective effect of melatonin against cisplatin‐induced testicular toxicity in rats
Ateşşahin, A., Şahna, E., Türk, G., Çeribaşi, A. O., Yılmaz, S., Yüce, A., & Bulmuş, Ö. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00327.x · Cited by 173
Doxorubicin-induced ovarian toxicity
Ben‐Aharon, I., Bar‐Joseph, H., Tzarfaty, G., Kuchinsky, L., Rizel, S., Stemmer, S. M., & Shalgi, R. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-20 · Cited by 172
Knobf, M. T. (2006) · The Oncologist · doi:10.1634/theoncologist.11-2-96 · Cited by 164
Ciurea, S. O., Al Malki, M. M., Kongtim, P., Fuchs, E. J., Luznik, L., Huang, X.-J., Ciceri, F., Locatelli, F., Aversa, F., Castagna, L., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0499-z · Cited by 163
Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63
Tuppi, M., Kehrloesser, S., Coutandin, D. W., Rossi, V., Luh, L. M., Strubel, A., Hötte, K., Hoffmeister, M., Schäfer, B., De Oliveira, T., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0035-7 · Cited by 160
Self-citationReichardt, P., Tabone, M.-D., Mora, J., Morland, B., & Jones, R. L. (2018) · Future Oncology · doi:10.2217/fon-2018-0210 · Cited by 160
Leonard, R. C. F., Adamson, D. J. A., Bertelli, G., Mansi, J., Yellowlees, A., Dunlop, J., Thomas, G. A., Coleman, R. E., & Anderson, R. A. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx184 · Cited by 159
Self-citationSonigo, C., Beau, I., Grynberg, M., & Binart, N. (2019) · The FASEB Journal · doi:10.1096/fj.201801089r · Cited by 159
Chang, E. M., Lim, E., Yoon, S.-Y., Jeong, K., Bae, S., Lee, D. R., Yoon, T. K., Choi, Y., & Lee, W. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144245 · Cited by 158
Environmental epigenetic inheritance through gametes and implications for human reproduction
Wei, Y., Schatten, H., & Sun, Q.-Y. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu061 · Cited by 157
Campbell, B. K., Clinton, M., & WEBB, R. (2012) · Endocrinology · doi:10.1210/en.2012-1158 · Cited by 156
Augmenting Chemosensitivity of Malignant Melanoma Tumors via Proteasome Inhibition
Amiri, K. I., Horton, L. W., LaFleur, B. J., Sosman, J. A., & Richmond, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0673 · Cited by 155
Yüksel, A., Bildik, G., Senbabaoglu, F., Akin, N., Arvas, M., Ünal, F., Kilic, Y., Karanfil, I., Eryılmaz, B., Yilmaz, P., et al. (2015) · Human Reproduction · doi:10.1093/humrep/dev256 · Cited by 153
Zhou, L., Xie, Y., Li, S., Liang, Y., Qiu, Q., Lin, H., & Zhang, Q. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0350-3 · Cited by 152
Pariente, R., Pariente, J. A., Rodríguez, A. B., & Espino, J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12288 · Cited by 151
Prevention of chemotherapy-induced ovarian damage
Roness, H., Kashi, O., & Meirow, D. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.043 · Cited by 151
Lepper, E. R., Nooter, K., Verweij, J., Acharya, M. R., Figg, W. D., & Sparreboom, A. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.2.115 · Cited by 142
Overbeek, A., van den Berg, M. H., van Leeuwen, F. E., Kaspers, G. J. L., Lambalk, C. B., & Broeder, E. V. D. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.006 · Cited by 141
Anti-Müllerian hormone initiates growth of human primordial follicles in vitro
Schmidt, K. L. T., Kryger‐Baggesen, N., Byskov, A. G., & Andersen, C. Y. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.12.010 · Cited by 137
Kim, S.-Y., Cordeiro, M. H., Serna, V. A., Ebbert, K., Butler, L. M., Sinha, S., Mills, A. A., Woodruff, T. K., & Kurita, T. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.31 · Cited by 136
Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility
Nguyen, Q., Zerafa, N., Liew, S. H., Morgan, F. H., Strasser, A., Scott, C. L., Findlay, J. K., Hickey, M., & Hutt, K. J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0633-7 · Cited by 135
Zapico, S. C., Rodríguez‐Blanco, J., García‐Santos, G., Martín, V., Sánchez‐Sánchez, A. M., Antolín, I., & Rodríguez, C. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00727.x · Cited by 133
Barberino, R. D. S., Menezes, V. G., Ribeiro, A. E. A. S., Palheta, R. C., Jiang, X., Smitz, J. E. J., & Matos, M. H. T. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox053 · Cited by 131
Roness, H., Kalich‐Philosoph, L., & Meirow, D. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu019 · Cited by 123
Ernst, E., Grøndahl, M. L., Grund, S., Hardy, K., Heuck, A., Sunde, L., Franks, S., Andersen, C. Y., Villesen, P., & Lykke‐Hartmann, K. (2017) · Human Reproduction · doi:10.1093/humrep/dex238 · Cited by 118
Bansod, S., Kageyama, R., & Ohtsuka, T. (2017) · Development · doi:10.1242/dev.147256 · Cited by 115
LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse
Rossi, V., Lispi, M., Longobardi, S., Mattei, M., Rella, F. D., Salustri, A., Felici, M. D., & Klinger, F. G. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.97 · Cited by 113
Self-citationGenetic Disease in the Children of Danish Survivors of Childhood and Adolescent Cancer
Winther, J. F., Olsen, J. H., Wu, H., Shyr, Y., Mulvihill, J. J., Stovall, M. A., Nielsen, A., Schmiegelow, M., & Boice, J. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.0504 · Cited by 111
Adhikari, D., Risal, S., Liu, K., & Shen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053810 · Cited by 110
Dexrazoxane for the treatment of chemotherapy-related side effects
Langer, S. (2014) · Cancer Management and Research · doi:10.2147/cmar.s47238 · Cited by 109
New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators
Sun, X., Su, Y., He, Y., Zhang, J., Liu, W., Zhang, H., Hou, Z., Liu, J., & Li, J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.995496 · Cited by 105
Lande, Y., Fisch, B., Tsur, A., Farhi, J., Prag-Rosenberg, R., Ben‐Haroush, A., Kessler‐Icekson, G., Zahalka, M. A., Ludeman, S. M., & Abir, R. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.10.005 · Cited by 105
Inferring biological mechanisms from spatial analysis: Prediction of a local inhibitor in the ovary
da Silva‐Buttkus, P., Marcelli, G., Franks, S., Stark, J., & Hardy, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810012106 · Cited by 103
Khedr, N. F. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215576304 · Cited by 97
Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes
Bar‐Joseph, H., Ben‐Aharon, I., Rizel, S., Stemmer, S. M., Tzabari, M., & Shalgi, R. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.07.003 · Cited by 96
Petrillo, S. K., Desmeules, P., Truong, T., & Devine, P. J. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.012 · Cited by 96
Xiao, S., Zhang, J., Liu, M., Iwahata, H., Rogers, H. B., & Woodruff, T. K. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx047 · Cited by 93
Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation
Damia, G., Filiberti, L., Vikhanskaya, F., Carrassa, L., Taya, Y., Dincalci, M., & Broggini, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900122 · Cited by 92
Jang, H. S., Na, Y., Hong, K., Lee, S. H., Moon, S., Cho, M., Park, M., Lee, O., Chang, E. M., Lee, D. R., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12432 · Cited by 92
Clinical relevance of melatonin in ovarian and placental physiology: a review
Reiter, R. J., Tan, D., Tamura, H., Cruz, M. H. C., & Fuentes‐Broto, L. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.849238 · Cited by 90
Chen, Z., Kang, X., Wang, L., Dong, H., Wang, C., Xiong, Z. Q., Zhao, W., Jia, C., Lin, J., Zhang, W., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.605261 · Cited by 86
Luo, Q., Yin, N., Zhang, L., Yuan, W., Zhao, W., Luan, X., & Zhang, H. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.05.001 · Cited by 85
Kim, S., Nair, D. M., Romero, M. M., Serna, V. A., Koleske, A. J., Woodruff, T. K., & Kurita, T. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0151-2 · Cited by 84
Effects of cancer treatment during pregnancy on fetal and child development
Vandenbroucke, T., Verheecke, M., Fumagalli, M., Lok, C. A. R., & Amant, F. C. (2017) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(17)30091-3 · Cited by 83
Ovarian function, fertility and reproductive lifespan in cancer patients
Jayasinghe, Y., Wallace, W. H., & Anderson, R. A. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1455498 · Cited by 82
Self-citationÖzcan, P., Fıçıcıoğlu, C., Yildirim, O. K., Özkan, F., Akkaya, H., & Aslan, İ. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.06.007 · Cited by 81
Epigenetic inheritance through the female germ-line: The known, the unknown, and the possible
Clarke, H. J., & Vieux, K.-F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.07.003 · Cited by 79
Clementi, M. E., Giardina, B., Stasio, E. D., Mordente, A., & Misiti, F. (2003) · PubMed · Cited by 75
Skaznik-Wikiel, M. E., McGuire, M. M., Sukhwani, M., Donohue, J., Chu, T., Krivak, T. C., Rajkovic, A., & Orwig, K. E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.01.135 · Cited by 69
Will Imatinib Compromise Reproductive Capacity?
Zamah, A. M., Mauro, M. J., Druker, B. J., Oktay, K., Egorin, M. J., Cedars, M. I., & Rosen, M. P. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0137 · Cited by 69
Bonnaud, S., Niaudet, C., Pottier, G., Gaugler, M., Millour, J., Barbet, J., Sabatier, L., & Paris, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2802 · Cited by 67
PUMA regulates germ cell loss and primordial follicle endowment in mice
Myers, M., Morgan, F. H., Liew, S. H., Zerafa, N., Gamage, T., Sarraj, M. A., Cook, M., Kapic, I., Sutherland, A., Scott, C. L., et al. (2014) · Reproduction · doi:10.1530/rep-13-0666 · Cited by 67
Bildik, G., Akin, N., Senbabaoglu, F., Şahin, G. N., Karahüseyinoğlu, S., İnce, Ü., Taşkıran, Ç., Selek, U., Yakın, K., Güzel, Y., et al. (2015) · Human Reproduction · doi:10.1093/humrep/dev257 · Cited by 65
Vitek, W., Shayne, M., Hoeger, K. M., Han, Y., Messing, S. P., & Fung, C. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.06.003 · Cited by 60
Pregnancy outcome in women treated with doxorubicin for childhood cancer
Bar, J., Davidi, O., Goshen, Y., Hod, M., Yaniv, I., & Hirsch, R. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00837-8 · Cited by 58
The Effect of Mirtazapine on Cisplatin‐Induced Oxidative Damage and Infertility in Rat Ovaries
Altuner, D., Gülaboğlu, M., Yapça, Ö. E., & Cetin, N. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/327240 · Cited by 58
Pharmacological Inhibition of the DNA Damage Checkpoint Prevents Radiation-Induced Oocyte Death
Rinaldi, V. D., Hsieh, K., Munroe, R., Bolcun‐Filas, E., & Schimenti, J. C. (2017) · Genetics · doi:10.1534/genetics.117.203455 · Cited by 54
Chemotherapy-Induced Late Transgenerational Effects in Mice
Kujjo, L. L., Chang, E. A., Pereira, R. J. G., Dhar, S. S., Marrero-Rosado, B. M., Sengupta, S., Wang, H., Cibelli, J. B., & Perez, G. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017877 · Cited by 52
Ezoe, K., Daikoku, T., Yabuuchi, A., Murata, N., Kawano, H., Abe, T., Okuno, T., Kobayashi, T., & Kato, K. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau065 · Cited by 52
Novel insights into the pathophysiology of chemotherapy-induced damage to the ovary
Bedoschi, G., Navarro, P. A., & Oktay, K. (2019) · Panminerva Medica · doi:10.23736/s0031-0808.18.03494-8 · Cited by 52
Tamoxifen Prevents Apoptosis and Follicle Loss from Cyclophosphamide in Cultured Rat Ovaries1
Piasecka‐Srader, J., Blanco, F. F., Delman, D. H., Dixon, D. A., Geiser, J. L., Ciereszko, R. E., & Petroff, B. K. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.126136 · Cited by 51
Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus
Kiyomiya, K.-I., Matsuo, S., & Kurebe, M. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00151-9 · Cited by 50
Schmidt, J. K., Roti, E. C. R., Ringelstetter, A. K., Khatib, H., Abbott, D. H., & Salih, S. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142588 · Cited by 46
Stem cells and pulmonary metamorphosis: New concepts in repair and regeneration
Aliotta, J. M., Passero, M. A., Meharg, J. V., Klinger, J. R., Dooner, M. S., Pimentel, J., & Quesenberry, P. J. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20318 · Cited by 45
Effect of doxorubicin-induced ovarian toxicity on mouse ovarian granulosa cells
Zhang, T., He, W. H., Feng, L., & Huang, H. G. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.02.012 · Cited by 45
Pajonk, F., van Ophoven, A., Weißenberger, C., & McBride, W. H. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-76 · Cited by 44
DNA as a Target for Anticancer Coordination Compounds
Roberts, J. J., & Pera, M. (1983) · ACS symposium series · doi:10.1021/bk-1983-0209.ch001 · Cited by 43
Tanaka, Y., Kimura, F., Zheng, L., Kaku, S., Takebayashi, A., Kasahara, K., Tsuji, S., & Murakami, T. (2018) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.18-0042 · Cited by 40
Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro
Asadi‐Azarbaijani, B., Sheikhi, M., Oskam, I. C., Nurmio, M., Laine, T., Tinkanen, H., Mäkinen, S., Tanbo, T. G., Hovatta, O., & Jahnukainen, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133985 · Cited by 38
Garcia, J. M., Chen, J., Guillory, B., Donehower, L. A., Smith, R. G., & Lamb, D. J. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.129759 · Cited by 37
Gaytán, F., Morales, C., León, S., García-Galiano, D., Roa, J., & Tena‐Sempere, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144099 · Cited by 35
Huang, H., Liu, N., Yang, C., Liao, S., Guo, H., Zhao, K., Li, X., Liu, S., Guan, L., Chunjiao, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052576 · Cited by 33
Tocotrienol preserves ovarian function in cyclophosphamide therapy
Saleh, H., Omar, E., Froemming, G. R. A., & Said, R. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327114564793 · Cited by 30
Li, S., Chen, J., Fang, X., & Xia, X. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1290072 · Cited by 29
Wang, Y., Liu, M., Zhang, J., Liu, Y., Kopp, M., Zheng, W., & Xiao, S. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy038 · Cited by 27
Bortezomib in Multiple Myeloma: A Practice Guideline
Kouroukis, C. T., Baldassarre, F. G., Haynes, A. E., Imrie, K., Reece, D. E., & Cheung, M. C. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.11.022 · Cited by 25
Kirsch‐Volders, M., Pacchierotti, F., Parry, E. M., Russo, A., Eichenlaub-Ritter, U., & Adler, I. ‐. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.11.002 · Cited by 25
Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice
Qin, Y., Iwase, A., Murase, T., Bayasula, Ishida, C., Kato, N., Nakamura, T., Osuka, S., Takikawa, S., Goto, M., et al. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0426-y · Cited by 21
Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats
Tsuyoshi, H., Orisaka, M., Fukuda, S., Hattori, K., Tsang, B. K., & Yoshida, Y. (2014) · Steroids · doi:10.1016/j.steroids.2014.10.010 · Cited by 19
Maternal cancer and congenital anomalies in children – a Danish nationwide cohort study
Momen, N. C., Ernst, A., Arendt, L. H., Olsen, J., Li, J., Gissler, M., Rasmussen, F. E., & Ramlau‐Hansen, C. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173355 · Cited by 18
Fertility, Cardiac, and Orthopedic Challenges in Survivors of Adult and Childhood Sarcoma
Lipshultz, E. R., Holt, G. E., Ramasamy, R., Yechieli, R. L., & Lipshultz, S. E. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_174708 · Cited by 12
Salih, S. M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.128 · Cited by 9
Correction: Chemotherapy-Induced Late Transgenerational Effects in Mice
Kujjo, L. L., Chang, E. A., Pereira, R. J. G., Dhar, S. S., Marrero-Rosado, B. M., Sengupta, S., Wang, H., Cibelli, J. B., & Perez, G. I. (2011) · PLoS ONE · doi:10.1371/annotation/4fffb4ef-31ad-4aab-bfce-2c97522c9af4 · Cited by 8
Cited by
ESHRE guideline: female fertility preservation
The ESHRE Guideline Group on Female Fertility Preservation, Anderson, R. A., Amant, F., Braat, D., D'Angelo, A., Chuva de Sousa Lopes, S. M., Demeestere, I., Dwek, S., Frith, L., Lambertini, M., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa052 · Cited by 748
Self-citationLambertini, M., Peccatori, F. A., Demeestere, I., Amant, F., Wyns, C., Stukenborg, J.-B., Paluch-Shimon, S., Halaska, M. J., Uzan, C., Meissner, J., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.006 · Cited by 500
Self-citationLustberg, M. B., Kuderer, N. M., Desai, A., Bergerot, C., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 306
Premature ovarian insufficiency: an international menopause society white paper
Panay, N., Anderson, R. A., Nappi, R. E., Vincent, A. J., Vujovic, S., Webber, L., & Wolfman, W. (2020) · Climacteric · doi:10.1080/13697137.2020.1804547 · Cited by 297
Self-citationLi, L., He, D., Guo, Q., Zhang, Z., Ru, D., Wang, L., Gong, K., Liu, F., Duan, Y., & Li, H. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01264-5 · Cited by 206
Metadata
- Authors
- Spears, N., Lopes, F., Stefansdottir, A., Rossi, V, De Felici, M., Anderson, R. A., & Klinger, F. G.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-10-10
- Volume
- 25
- Issue
- 6
- Pages
- 673-693
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2980216096
- Cited by
- 657
- References
- 142
- FWCI
- 47.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.